ORS 475A.200 Legislative findings

The People of the State of Oregon find that:

Oregon has one of the highest prevalences of mental illness among adults in the nation;

An estimated one in every five adults in Oregon is coping with a mental health condition;

The Governor has declared addiction as a public health crisis in this state;

The 2019-2021 Governor’s Budget proposes spending over $2.8 billion on mental health and behavioral health programs;

Studies conducted by nationally and internationally recognized medical institutions indicate that psilocybin has shown efficacy, tolerability, and safety in the treatment of a variety of mental health conditions, including but not limited to addiction, depression, anxiety disorders, and end-of-life psychological distress;

The United States Food and Drug Administration has:

Determined that preliminary clinical evidence indicates that psilocybin may demonstrate substantial improvement over available therapies for treatment-resistant depression; and

Granted a Breakthrough Therapy designation for a treatment that uses psilocybin as a therapy for such depression;

The Oregon Health Authority has direct supervision of all matters relating to the preservation of life and health of the people of this state;

During a two-year program development period, the authority should:

Examine, publish, and distribute to the public available medical, psychological, and scientific studies, research, and other information relating to the safety and efficacy of psilocybin in treating mental health conditions; and

Adopt rules and regulations for the eventual implementation of a comprehensive regulatory framework that will allow persons

21 years of age and older in this state to be provided psilocybin services; and

An advisory board should be established within the authority for the purpose of advising and making recommendations to the authority.

leadline to ORS 475A.200 read “Findings.” The leadline was changed by editorial action.